374 results on '"Gada, Hemal"'
Search Results
2. Improved Hemodynamics With Self-Expanding Compared to Balloon-Expandable Transcatheter Aortic Valve Implantation in Small Annulus Patients: A Propensity-Matched Analysis
3. Decreasing pacemaker implantation rates with Evolut supra-annular transcatheter aortic valves in a large real-world registry
4. Use and performance of the evolut FX transcatheter aortic valve system
5. Management of Postprocedural Conduction Disturbances Using a Prespecified Algorithm in the Optimize PRO Study
6. 1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results
7. 1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation
8. Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial)
9. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study
10. Transcatheter Left Ventricular Restoration in Patients With Heart Failure
11. Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study
12. Propensity-Matched Outcomes Comparing TAVR in Bicuspid vs Surgery in Tricuspid Aortic Valve Stenosis
13. Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study
14. Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients
15. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients
16. Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial)
17. 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.
18. First Experience With Amulet in the United States
19. Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry
20. Double S-Curve Versus Cusp-Overlap Technique: Defining the Optimal Fluoroscopic Projection for TAVR With a Self-Expanding Device
21. Transcatheter Approaches to Aortic Insufficiency
22. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
23. Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial)
24. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial
25. 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial
26. Transcatheter aortic valve replacement associated infective endocarditis case series: broadening the criteria for diagnosis is the need of the hour
27. In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry
28. Staying in the Shallow End: Minimizing Permanent Pacemaker Implantation With a Novel Implantation Method
29. National Variability in Pacemaker Implantation Rate Following TAVR: Insights From the STS/ACC TVT Registry.
30. Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Results From the Evolut FX Limited Market Release Clinical Survey
31. TAVR in Intermediate-Risk Patients: 5-Year Outcomes From the SURTAVI Continued Access Study
32. OR3-6 | Early Outcomes from the Optimize PRO TAVR Care Pathway Evolut FX System Addendum Study
33. LB-8 | Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Updated Results from the Evolut FX Limited Market Release Clinical Survey
34. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
35. Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis
36. Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations
37. COMPUTED TOMOGRAPHY TO ASSESS FEASIBILITY OF CORONARY ACCESS FOLLOWING BALLOON-EXPANDABLE VALVE IMPLANTATION WITHIN A SUPRA-ANNULAR TRANSCATHETER VALVE
38. BIOPROSTHETIC VALVE FRACTURE IN PATIENTS UNDERGOING SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT IN A FAILED SURGICAL VALVE: REAL-WORLD OUTCOMES FROM THE TRANSCATHETER VALVE THERAPY REGISTRY
39. CRT-700.33 Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Results From the Evolut FX Limited Market Release Clinical Survey
40. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk
41. CRT-700.03 TAVR in Intermediate-Risk Patients: 5-Year Outcomes From the SURTAVI Continued Access Study
42. Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk Trial
43. Amulet Occluder Implantation in Patients With Failed Prior Left Atrial Appendage Occlusion: EMERGE LAA Insights.
44. Meta-Analysis of Trials on Mortality After Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia
45. Aortic Annulus S-Curve
46. Outcomes of transcatheter aortic valve replacement at teaching versus nonteaching hospitals
47. TCT-463 Adherence to Key Cusp Overlap Steps Reduced Pacemaker Implantation in the Optimize PRO Study
48. Automated Surveillance of Hemodynamic Valve Performance via an Integrated Artificial Intelligence Platform
49. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neo-Skirt Height and Leaflet Overhang
50. Effect of COVID-19 Surveillance Testing on Patient Perceptions in Outpatients Undergoing Cardiovascular Procedures: Results From the Restoring Non-Emergent Cardiovascular Care in the Peri-COVID-19 Era (RECIPE) Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.